Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma

被引:72
|
作者
Landwehr, Laura-Sophie [1 ]
Altieri, Barbara [1 ]
Schreiner, Jochen [1 ]
Sbiera, Iuliu [1 ]
Weigand, Isabel [1 ]
Kroiss, Matthias [1 ,2 ]
Fassnacht, Martin [1 ,2 ,3 ]
Sbiera, Silviu [1 ,2 ]
机构
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany
[2] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Clin Chem & Lab Med, Wurzburg, Germany
关键词
immunity; immunotherapy; lymphocytes; tumor-infiltrating; t-lymphocytes; tumor microenvironment; REGULATORY T-CELLS; EUROPEAN-SOCIETY; PHASE-II; CANCER; COLLABORATION; PEMBROLIZUMAB; MANAGEMENT; NIVOLUMAB; SURVIVAL; EFFICACY;
D O I
10.1136/jitc-2019-000469
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in similar to 60% of patients and associated with particularly poor prognosis. Results of first clinical trials using immune checkpoint inhibitors were heterogeneous. Here we characterize tumor-infiltrating T lymphocytes (TILs) in ACC in association with glucocorticoids as potential explanation for resistance to immunotherapy. Methods We performed immunofluorescence analysis to visualize tumor-infiltrating T cells (CD3(+)), T helper cells (CD3(+)CD4(+)), cytotoxic T cells (CD3(+)CD8(+)) and regulatory T cells (Tregs; CD3(+)CD4(+)FoxP3(+)) in 146 ACC tissue specimens (107 primary tumors, 16 local recurrences, 23 metastases). Quantitative data of immune cell infiltration were correlated with clinical data (including glucocorticoid excess). Results 86.3% of ACC specimens showed tumor infiltrating T cells (7.7 cells/high power field (HPF)), including T helper (74.0%, 6.7 cells/HPF), cytotoxic T cells (84.3%, 5.7 cells/HPF) and Tregs (49.3%, 0.8 cells/HPF). The number of TILs was associated with better overall survival (HR for death: 0.47, 95% CI 0.25 to 0.87), which was true for CD4(+)- and CD8(+) subpopulations as well. In localized, non-metastatic ACC, the favorable impact of TILs on overall and recurrence-free survival was manifested even independently of ENSAT (European Network for the Study of Adrenal Tumors) stage, resection status and Ki67 index. T helper cells were negatively correlated with glucocorticoid excess (Phi=-0.290, p=0.009). Patients with glucocorticoid excess and low TILs had a particularly poor overall survival (27 vs. 121 months in patients with TILs without glucocorticoid excess). Conclusion Glucocorticoid excess is associated with T cell depletion and unfavorable prognosis. To reactivate the immune system in ACC by checkpoint inhibitors, an inhibition of adrenal steroidogenesis might be pivotal and should be tested in prospective studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma
    Jakubowska, Katarzyna
    Kisielewski, Wojciech
    Kanczuga-Koda, Luiza
    Koda, Mariusz
    Famulski, Waldemar
    ONCOLOGY LETTERS, 2017, 14 (06) : 6421 - 6432
  • [2] The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study
    El-Rebey, Hala S.
    Abdou, Asmaa G.
    Sultan, Mervat M.
    Ibrahim, Shymaa H.
    Holah, Nanis S.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (03) : 188 - 200
  • [3] Identification of lncRNA Signature of Tumor-Infiltrating T Lymphocytes With Potential Implications for Prognosis and Chemotherapy of Head and Neck Squamous Cell Carcinoma
    Wang, Liping
    Yang, Gui
    Liu, Guohong
    Pan, Yunbao
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [4] Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma
    Vargas, Gracia Maria
    Shafique, Neha
    Xu, Xiaowei
    Karakousis, Giorgos
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (04) : 299 - 310
  • [5] Tumor-Infiltrating Lymphocytes in Melanoma
    Lee, Sylvia
    Margolin, Kim
    CURRENT ONCOLOGY REPORTS, 2012, 14 (05) : 468 - 474
  • [6] Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma
    Tille, Jean-Christophe
    Vieira, Andre F.
    Saint-Martin, Caroline
    Djerroudi, Lounes
    Furhmann, Laetitia
    Bidard, Francois-Clement
    Kirova, Youlia
    Tardivon, Anne
    Reyal, Fabien
    Carton, Matthieu
    Vincent-Salomon, Anne
    MODERN PATHOLOGY, 2020, 33 (11) : 2198 - 2207
  • [7] Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma
    Zhang, Siqin
    Chen, Shaoyong
    Wang, Yuchen
    Zhan, Yuxiang
    Li, Jiarui
    Nong, Xiaolin
    Gao, Biyun
    FRONTIERS IN GENETICS, 2021, 12
  • [8] Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma
    dos Santos, Fernando De Marco
    da Silva, Felipe Correa
    Pedron, Julia
    Furian, Roque Domingos
    Fortes, Cristina
    Bonamigo, Renan Rangel
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (01) : 47 - 51
  • [9] CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
    Wang, Bo
    Wu, Shaoxu
    Zeng, Hong
    Liu, Zhuowei
    Dong, Wen
    He, Wang
    Chen, Xu
    Dong, Xiaoliang
    Zheng, Limin
    Lin, Tianxin
    Huang, Jian
    JOURNAL OF UROLOGY, 2015, 194 (02) : 556 - 562
  • [10] Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management
    Shirabe, Ken
    Motomura, Takashi
    Muto, Jun
    Toshima, Takeo
    Matono, Rumi
    Mano, Yohei
    Takeishi, Kazuki
    Ijichi, Hideki
    Harada, Noboru
    Uchiyama, Hideaki
    Yoshizumi, Tomoharu
    Taketomi, Akinobu
    Maehara, Yoshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (06) : 552 - 558